Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms, Castration-Resistant × Exome Sequencing × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Sebaceous Cell Tumor of Eyelid 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1 Neoplasms 1 Hematologic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

enzalutamide 19 Abiraterone Acetate 11 Prednisone 7 Docetaxel 6 radium Ra 223 dichloride 5 darolutamide 5 abiraterone 5 apalutamide 3 niraparib 2 cabazitaxel 2 Nivolumab 2 zimberelimab 1 xentuzumab 1 tasquinimod 1 sacituzumab govitecan 1 sabizabulin 1 quemliclustat 1 pembrolizumab 1 olaparib 1 gedatolisib 1 gallium 68 PSMA-11 1 fludrocortisone acetate 1 atezolizumab 1 TVB-2640 1 Standard of Care 1 Rosuvastatin Calcium 1 Radium-223 1 Radiosurgery 1 Pluvicto 1 Pioglitazone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04126915 2019-11-05

PTtWES

Changhai Hospital

Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡